Purple Biotech Ltd.
Develops cancer therapies to overcome tumor immune evasion and drug resistance.
PPBT | TA
Overview
Corporate Details
- ISIN(s):
- IL0007650166
- LEI:
- Country:
- Israel
- Address:
- Oppenheimer 4, 7670104 Rehovot
- Website:
- https://purple-biotech.com/
- Sector:
- Manufacturing
Description
Purple Biotech Ltd. is a clinical-stage company that develops first-in-class therapies for cancer patients. The company focuses on advancing treatments designed to overcome tumor immune evasion and drug resistance, with the goal of providing effective and durable therapeutic solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-29 07:41 |
Immediate Report of Meeting
|
English | 60.9 KB | ||
| 2025-10-29 07:26 |
Immediate Report
|
English | 519.1 KB | ||
| 2025-10-29 07:26 |
Immediate Report
|
English | 36.6 KB | ||
| 2025-10-21 08:21 |
Other Report or Announcement
|
English | 181.6 KB | ||
| 2025-10-21 08:21 |
Other Report or Announcement
|
English | 36.6 KB | ||
| 2025-09-21 10:55 |
AT THE MARKET OFFERING AGREEMENT
|
English | 704.8 KB | ||
| 2025-09-21 10:55 |
AT THE MARKET OFFERING AGREEMENT
|
English | 36.6 KB | ||
| 2025-09-21 10:51 |
PROSPECTUS SUPPLEMENT (At-the-Market)
|
English | 471.1 KB | ||
| 2025-09-21 10:51 |
PROSPECTUS SUPPLEMENT (At-the-Market)
|
English | 36.6 KB | ||
| 2025-09-16 14:31 |
CORPORATE PRESETATION- SEPTEMBER 2025
|
English | 36.5 MB | ||
| 2025-09-16 14:31 |
CORPORATE PRESETATION- SEPTEMBER 2025
|
English | 36.7 KB | ||
| 2025-09-10 17:04 |
Receives Intention to Grant a European Patent Covering NT219 Combinations with …
|
English | 158.1 KB | ||
| 2025-09-10 17:04 |
Receives Intention to Grant a European Patent Covering NT219 Combinations with …
|
English | 36.7 KB | ||
| 2025-09-07 11:04 |
Announces Closing of Up To $18 Million Public Offering $6 million upfront with …
|
English | 82.3 KB | ||
| 2025-09-07 11:04 |
Announces Closing of Up To $18 Million Public Offering $6 million upfront with …
|
English | 36.7 KB |
Automate Your Workflow. Get a real-time feed of all Purple Biotech Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Purple Biotech Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Purple Biotech Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
